相关实验视频

Updated: Jun 20, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

微RNA:Siglec交叉在癌症进展中的作用

D Mustafov¹, M S Ahmad², A Serrano³

¹School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK; College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK.

Current opinion in chemical biology

|July 19, 2024

概括

在瘤中异常的Siglec表达促进免疫逃避并影响生存. 用微RNA准Siglec/酸轴为癌症进展提供了新的诊断和治疗策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

瘤微环境中的异常Siglec (酸结合性免疫球蛋白类似的莱克) 表达与癌症恶性有关,影响瘤行为和患者的生存.
西格莱克与sialoglycans的接触可以掩盖抗原,促进免疫逃避,并表明瘤内的免疫功能失调.
了解瘤进展期间的Siglec表达特征对于开发有效的癌症疗法至关重要.

研究的目的:

阐明Siglec表达在瘤进展中的作用及其对瘤微环境的影响.
探索微RNAs (miRNAs) 在调节Siglec表达中的潜力,用于治疗应用.
在癌症的背景下审查miRNA:Siglec相互作用的当前文献,并确定潜在的诊断和治疗策略.

主要方法:

对研究研究瘤中的Siglec表达的文献综述.
与Siglecs.相关的miRNA向机制的分析.
在癌症免疫学中探索Siglec/酸轴.

主要成果:

西格莱克的失调是瘤免疫逃避和进展的重要因素.
微RNA代表了针对Siglec表达的有希望的途径.
目前的文献表明,针对Siglec/酸轴的潜在诊断和治疗应用.

结论:

准可能由miRNAs调节的Siglec/酸轴,可能为癌症治疗提供新的策略.
对miRNA-Siglec相互作用的进一步研究是有必要的,以开发新的免疫疗法.
阐明Siglec表达特征是了解瘤进展和改善患者治疗结果的关键.

更多相关视频

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...